Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
Running, not enrolling · Phase 2
Conditions studied: Cutaneous Squamous Cell Carcinoma, Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
In brief
To estimate the clinical benefit of cemiplimab monotherapy versus cemiplimab in combination with RP1 for patients with locally advanced or metastatic CSCC, as assessed by overall response rate (ORR) and complete response rate (CRR) according to blinded independent review.
Key facts
- Study ID
- NCT04050436
- Run by
- Replimune, Inc.
- People needed
- 231
- Starts
- 2019-10-08
- Expected to finish
- 2025-09-01
- Last updated by the study team
- 2025-01-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California Los Angeles — Los Angeles, California, United States
- Stanford University — Stanford, California, United States
- University of Colorado Cancer Center — Aurora, Colorado, United States
- University of Miami Health System — Miami, Florida, United States
- Orlando Health UF Health Cancer Center — Orlando, Florida, United States
- Moffitt McKinley Outpatient Center — Tampa, Florida, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- John Theurer Cancer Center at Hackensack Univeristy Medical Center — Hackensack, New Jersey, United States
- Memorial Sloan Kettering Cancer Center — New York, New York, United States
- University Of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
- Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States
- Prisma Health Cancer Institute — Greenville, South Carolina, United States
- MD Anderson Cancer Center — Houston, Texas, United States
- Chris O'Brien Lifehouse — Camperdown, New South Wales, Australia
- Cancer Care Wollongong Pty Limited — Wollongong, New South Wales, Australia
- Tasman Oncology Research Ltd — Southport, Queensland, Australia
- Monash Medical Centre — Clayton, Victoria, Australia
- Peter MacCallum Cancer Centre — Melbourne, Victoria, Australia
- The Alfred Hospital — Melbourne, Victoria, Australia
- Sir Charles Gairdner Hospital — Nedlands, Western Australia, Australia
- Multiprofile Hospital for Active Treatment - Uni Hospital" OOD Department of Medical Oncology — Panagyurishte, Bulgaria
- "Complex Oncology Center - Plovdiv" EOOD Department of Medical Oncology and Cutaneous Cancer Diseases " — Plovdiv, Bulgaria
- Sunnybrook Health Science Centre — Toronto, Ontario, Canada
- CHU Besancon - Hopital Jean Minjoz — Besançon, France
- University of California San Diego — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.